Continuing Medical Education (CME) for KARE: Knowledge Assessment REsource, 2023 Edition

The American Society of Pediatric Hematology/Oncology (ASPHO) will offer CME credit for self-assessment questions that are answered and evaluated. A certificate will be issued upon completion of the evaluation for each product.

The American Society of Pediatric Hematology/Oncology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The American Society of Pediatric Hematology/Oncology designates this enduring material for a maximum of 33.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ASPHO offers its evaluation in an online format and it may be completed after answering the self-assessment questions in test mode. Partial CME is not offered for the KARE questions. Participants receive their certificates immediately when they submit their evaluation. We encourage all attendees to complete their evaluation regardless of whether they are seeking CME credit. 

MOC Part 2

Purchasers will receive 33.75 MOC Part 2 points for the KARE questions once a score of 70% or higher is obtained at the completion of all self-assessment questions in test mode.

Successful completion of this CME activity, which includes participation in the activity, with individual assessments of the participant and feedback to the participant, enables the participant to earn 33.75 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABP MOC credit.

Disclosure

ASPHO requires that planners and presenters disclose the existence of any relevant financial or other relationship they and/or their spouse/partner have with the manufacturers of any commercial interest (defined as any entity producing, marketing, reselling, or distributing healthcare goods or services consumed by or used on patients) whose products or services relate to the topics presented. ASPHO also requires disclosure of the intent to discuss unlabeled or investigational use(s) of a commercial product. The ASPHO Accreditation Subcommittee of the Education Committee reviews potential conflicts of interest as submitted by planners and presenters and resolves such conflicts to ensure the content of the activity is aligned with the interests of the public.

View the 2023 Review Course speaker, planner, reviewer, and staff disclosures here.

Disclaimer

The material presented in this activity represents the opinion of the speakers and not necessarily the views of ASPHO.